Finding studies

Clareo Health | Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial

Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study